A new protein that appears to play a role in mitochondrial disease – a rare condition where a lack of energy in cells means that they can’t function properly – could prove to be important in conditions such as Alzheimer’s, Parkinson’s and Huntington’s diseases.
Patients, families and medical staff came together for a celebratory event at LEGOLAND® Windsor Resort to mark the 1000th deaf patient to be treated with cochlear implants by Great Ormond Street Hospital (GOSH).
Great Ormond Street Hospital for Children NHS Foundation Trust and the Institute of Child Health, University College London are pleased to announce that, following an international search, Professor Thomas Voit, MD, Dr. med. habil., has been appointed Director Designate of their Biomedical Research Centre (BRC).
Non-invasive prenatal testing (NIPT) for Down’s syndrome is safe, effective, and leads to a greater number of parents taking up the test, researchers at Great Ormond Street Hospital say. This is the finding of a study carried out at GOSH, who have the first laboratory in the NHS to provide NIPT testing.
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
A study co-led by Great Ormond Street Hospital’s research partner, the UCL Institute of Child Health (ICH), and the University of Oxford has identified a new way to heal a patient’s heart following a heart attack, representing an exciting step forward in regenerative medicine.